New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2014
07:11 EDTMYGNMyriad Genetics says SGO recommendations support broader genetic test access
Myriad Genetics noted that the Society of Gynecologic Oncology, or SGO, has issued new clinical practice statements surrounding hereditary cancer testing for patients with ovarian and endometrial cancer. The statements are consistent with the recently revised National Comprehensive Cancer Network, or NCCN, guidelines and support broader access to genetic testing for patients with ovarian and endometrial cancer, the company said. Some of the key aspects of the statements include a recommendation that women diagnosed with epithelial ovarian, tubal and peritoneal cancers should be considered for genetic counseling and testing even in the absence of family history and a recommendation that all women diagnosed with endometrial cancer should undergo systematic clinical screening and/or molecular screening for hereditary colon cancer risk.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:21 EDTMYGNMyriad denied appeal to block competing breast cancer tests, Bloombeg reports
Subscribe for More Information
December 11, 2014
12:54 EDTMYGNMyriad Genetics management to meet with William Blair
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use